Dare Bioscience (DARE) Misses Q3 EPS by 55c

Dare Bioscience (NASDAQ: DARE) reported Q3 EPS of ($0.55). Revenue for the quarter came in at $41.69 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
• Stardust Power (SDST) Tops Q2 EPS by 1c